Live Updates: COVID-19 Cases
  • World 30,966,387
    World
    Confirmed: 30,966,387
    Active: 7,441,019
    Recovered: 22,564,711
    Death: 960,657
  • USA 6,961,364
    USA
    Confirmed: 6,961,364
    Active: 2,542,883
    Recovered: 4,214,779
    Death: 203,702
  • India 5,398,230
    India
    Confirmed: 5,398,230
    Active: 1,011,732
    Recovered: 4,299,724
    Death: 86,774
  • Brazil 4,528,240
    Brazil
    Confirmed: 4,528,240
    Active: 571,613
    Recovered: 3,820,095
    Death: 136,532
  • Russia 1,097,251
    Russia
    Confirmed: 1,097,251
    Active: 171,450
    Recovered: 906,462
    Death: 19,339
  • Peru 762,865
    Peru
    Confirmed: 762,865
    Active: 123,659
    Recovered: 607,837
    Death: 31,369
  • Mexico 688,954
    Mexico
    Confirmed: 688,954
    Active: 123,959
    Recovered: 492,192
    Death: 72,803
  • South Africa 659,656
    South Africa
    Confirmed: 659,656
    Active: 54,282
    Recovered: 589,434
    Death: 15,940
  • Spain 659,334
    Spain
    Confirmed: 659,334
    Active: 628,839
    Recovered: ?
    Death: 30,495
  • Chile 444,674
    Chile
    Confirmed: 444,674
    Active: 14,319
    Recovered: 418,101
    Death: 12,254
  • France 442,194
    France
    Confirmed: 442,194
    Active: 319,346
    Recovered: 91,574
    Death: 31,274
  • Iran 419,043
    Iran
    Confirmed: 419,043
    Active: 37,293
    Recovered: 357,632
    Death: 24,118
  • UK 390,358
    UK
    Confirmed: 390,358
    Active: 348,599
    Recovered: ?
    Death: 41,759
  • Bangladesh 347,372
    Bangladesh
    Confirmed: 347,372
    Active: 88,073
    Recovered: 254,386
    Death: 4,913
  • Saudi Arabia 329,271
    Saudi Arabia
    Confirmed: 329,271
    Active: 15,383
    Recovered: 309,430
    Death: 4,458
  • Pakistan 305,031
    Pakistan
    Confirmed: 305,031
    Active: 6,572
    Recovered: 292,044
    Death: 6,415
  • Turkey 301,348
    Turkey
    Confirmed: 301,348
    Active: 27,786
    Recovered: 266,117
    Death: 7,445
  • Italy 296,569
    Italy
    Confirmed: 296,569
    Active: 43,161
    Recovered: 217,716
    Death: 35,692
  • Germany 272,308
    Germany
    Confirmed: 272,308
    Active: 19,342
    Recovered: 243,500
    Death: 9,466
  • Canada 142,774
    Canada
    Confirmed: 142,774
    Active: 9,376
    Recovered: 124,187
    Death: 9,211
  • Netherlands 91,934
    Netherlands
    Confirmed: 91,934
    Active: 85,659
    Recovered: ?
    Death: 6,275
  • China 85,269
    China
    Confirmed: 85,269
    Active: 171
    Recovered: 80,464
    Death: 4,634
  • Australia 26,885
    Australia
    Confirmed: 26,885
    Active: 2,079
    Recovered: 23,962
    Death: 844
  • S. Korea 22,893
    S. Korea
    Confirmed: 22,893
    Active: 2,545
    Recovered: 19,970
    Death: 378
  • New Zealand 1,811
    New Zealand
    Confirmed: 1,811
    Active: 67
    Recovered: 1,719
    Death: 25

Scientists found a new way to advance the delivery of therapeutic mRNA to human cells

Author at TechGenyz Science
Messenger RNA

MIT scientists discovered new materials that can support an improved way of delivering messenger RNA into human cells.

This mRNA is a large nucleic acid with the ability to encode genetic information, and can as well direct cells for producing specific proteins. It is not permanently inserted into the genome of a cell unlike DNA, which makes way to use it to produce a therapeutic protein that’s required temporarily. It can be used for producing gene-editing proteins too, altering genomes, and then it will just disappear minimizing the risk of off-target effects.

The large size of mRNA has been challenging for researchers to design it for inserting into cells, and into specific body organs, efficiently. Amino-polyesters that can package mRNA into polymers take care of these issues.

While conducting tests on mice, it was observed that several particles can efficiently deliver mRNA, and can too induce cells for protein synthesizing that’s encoded by mRNA. The best part is that these nanoparticles actually targeted specific organs like the heart, lungs, liver, and spleen. This opens space for researchers to provide specific therapies for certain organs and locations of the human body.

One of the studies they are to perform ahead is what makes these nanoparticles target certain organs. The findings are to be useful in diagnosis and cure of many diseases like pulmonary hypertension, vaccines to immune cells in the spleen, and more. These will be useful even in the CRISPR-Cas9 applications that can handle permanent additions or deletions to a genome!

This research was funded by the Progetto Roberto Roca and the US Defense Advanced Research Projects Agency. Present works of the MIT scientists concern collaboration with the Polytechnic University of Milan on the next-gen of the polymers to improve RNA delivery and to enhance the ability of the particles in targeting specific organs.

Career

Subscribe